CIK 0001534969 · Services-Medical Laboratories (SIC 8071) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Revenue (USD) | 81000 | 306000 | |
| Net income (USD) | -31.9 M | -36.2 M | -44.2 M |
| Diluted EPS (USD/shares) | -0.67 | -1.16 | -1.43 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-13 | 4 | 4 | 2026-10-12 |
| 2026-10-13 | 144 | 144 | |
| 2026-09-11 | 4 | 4 | 2026-09-10 |
| 2026-09-11 | 4 | 4 | 2026-09-10 |
| 2026-09-11 | 4 | 4 | 2026-09-10 |
| 2026-09-11 | 4 | 4 | 2026-09-10 |
| 2026-09-11 | 144 | 144 | |
| 2026-09-11 | 144 | 144 | |
| 2026-09-11 | 144 | 144 | |
| 2026-09-11 | 144 | 144 | |
| 2026-09-11 | 144 | 144 | |
| 2026-09-09 | 4 | 4 | 2026-09-08 |
| 2026-09-09 | 144 | 144 | |
| 2026-09-09 | 144 | 144 | |
| 2026-09-02 | 4 | 4 | 2026-08-31 |
| 2026-09-01 | 4 | 4 | 2026-08-31 |
| 2026-09-01 | 3 | 3 | 2026-08-31 |
| 2026-08-19 | 8-K | 8-K items 5.02,7.01,9.01 | 2026-08-14 |
| 2026-08-12 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-12 | 8-K | 8-K items 2.02,9.01 | 2026-08-12 |
| 2026-07-15 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-07-14 | 4 | 4 | 2026-07-10 |
| 2026-07-14 | 4 | 4 | 2026-07-10 |
| 2026-07-14 | 4 | 4 | 2026-07-10 |
| 2026-07-14 | 4 | 4 | 2026-07-10 |
Forms on file (last 1,000): 4 283, 144 177, 8-K 52, 3 28, 10-Q 16, SC 13G/A 9, D 9, SC 13G 8. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=SERA (0.002 USD), /gw/filings/filings?ticker=SERA&form=8-K, /gw/filings/facts?ticker=SERA&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange